usdept depart health human servic usdept usbureau center diseas control prevent usbureau cooper research develop agreement rindock crada 94001 rindock agenc agenc center diseas control prevent cdc public health servic hh agenc action action notic action summari summari center diseas control prevent cdc nation center infecti diseas announc opportun potenti collabor enter cooper research develop agreement crada develop refin valid three interrel technolog 1 exchang templat reaction etr method assembl synthet gene 2 construct hepat c viru hcv specif mosaic protein compos immunodomin antigen epitop 3 differenti hcv diagnost test anticip new technolog invent may aris crada licens collabor crada made crada design facilit develop scientif technolog knowledg use market product great deal freedom given feder agenc implement collabor research cdc may accept staff facil equip suppli money particip crada cdc may provid staff facil equip suppli project singl restrict exchang cdc may provid fund particip crada opportun avail 30 day public notic respond may provid longer period time furnish addit inform cdc find necessari summari inform contact technic howard field ph hepat branch divis viral rickettsi diseas nation center infecti diseas center diseas control prevent cdc 1600 clifton road ne mailstop g14 atlanta ga 30333 telephon 404 6392335 busi lisa blake dispigna technolog transfer repres nation center infecti diseas center diseas control prevent cdc 1600 clifton road ne mailstop c19 atlanta ga 30333 telephon 404 6393227 supplem supplementari inform goal crada bring market hcv specif technolog improv public health cdc provid intellectu insight experiment design protocol 1 improv effici etr 2 construct mosaic protein hcv immunodiagnost potenti vaccin relev 3 evalu synthet peptid contain antigen epitop reagent discrimin recent late infect may predict outcom hcv infect cdc design conduct feasibl experi project area contribut prepar serolog panel valid variou test format crada partner prepar synthet peptid oligonucleotid necessari project area prepar monospecif monoclon antibodi whenev appropri purifi antigen recombin lysat need collabor util expertis market research evalu commerci technolog respond provid evid expertis develop evalu diagnost assay evid experi commerci diagnost product support data e g public profici test certif resum etc qualif principl investig would involv crada respond develop final research plan collabor cdc applic submiss judg accord follow criteria 1 expertis diagnost virolgoy 2 evid scientif credibl 3 evid commit abil develop innov design diagnost assay vaccin 4 evid prepar synthet peptid oligonucleotid 5 evid strong engin depart design autom equip 6 evid exist infrastructur commerci success technolog crada propos implement 1986 feder technolog transfer act public law 99502 15 u c 3710 respons must made lisa blake despigna technolog transfer coordin nation center infecti diseas center diseas control prevent cdc 1600 clifton road ne mailstop c19 atlanta ga 30333 date june 29 1994 supplem signer arthur c jackson signer signjob associ director manag oper center diseas control prevent cdc signjob frfile fr doc 9416281 file 7594 8 45 frfile bill bill code 416318p bill